# CIETAI and Sequential Radiotherapy in Squamous Lung Cancer

> **NCT05892237** · PHASE2 · RECRUITING · sponsor: **Dong Wang** · enrollment: 50 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **PROCEDURE:** bronchial artery interventional therapy
- **DRUG:** Chemotherapy drug
- **RADIATION:** IMRT
- **DRUG:** Immunotherapy

## Key facts

- **NCT ID:** NCT05892237
- **Lead sponsor:** Dong Wang
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2025-02-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05892237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05892237, "CIETAI and Sequential Radiotherapy in Squamous Lung Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05892237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*